
Google is again facing questions from regulators about its $2.1 billion bid for Fitbit. The biggest sticking point: How will the tech giant use Fitbit’s trove of health data?
Google is staring down the possibility of a sweeping antitrust investigation launched by regulators in the European Union, which would become the latest in a series of probes into the deal. But the tech giant could sidestep that investigation by making a binding pledge not to use Fitbit’s health data for advertising purposes, Reuters reported this week. The deadline for Google to make such a concession is July 13. The European Commission, which is overseeing the probe, is scheduled to make a decision by July 20.
What is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.